{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:49Z","timestamp":1791407029598,"version":"4.3.3"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230236-4\"><jats:title>Importance<\/jats:title><jats:p>Bariatric surgery (BS) is associated with significantly reduced incidence of cardiovascular diseases and mortality in patients with obesity. However, whether BS can decrease major adverse cardiovascular events in patients with nonalcoholic fatty liver disease (NAFLD) remains poorly understood.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230236-5\"><jats:title>Objective<\/jats:title><jats:p>To investigate the association of BS with the incidence of adverse cardiovascular events and all-cause mortality in patients with NAFLD and obesity.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230236-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This was a large, population-based, retrospective cohort using data from the TriNetX platform. Adult patients with a body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) of 35 or greater and NAFLD (without cirrhosis) who underwent BS between January 1, 2005, and December 31, 2021, were included. Patients in the BS group were matched with patients who did not undergo surgery (non-BS group) according to age, demographics, comorbidities, and medication by using 1:1 propensity matching. Patient follow-up ended on August 31, 2022, and data were analyzed in September 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230236-7\"><jats:title>Exposures<\/jats:title><jats:p>Bariatric surgery vs nonsurgical care.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230236-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcomes were defined as the first incidence of new-onset heart failure (HF), composite cardiovascular events (unstable angina, myocardial infarction, or revascularization, including percutaneous coronary intervention or coronary artery bypass graft), composite cerebrovascular disease (ischemic or hemorrhagic stroke, cerebral infarction, transient ischemic attack, carotid intervention, or surgery), and a composite of coronary artery procedures or surgeries (coronary stenting, percutaneous coronary intervention, or coronary artery bypass). Cox proportional hazards models were used to estimate hazard ratios (HRs).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230236-9\"><jats:title>Results<\/jats:title><jats:p>Of 152\u202f394 eligible adults, 4693 individuals underwent BS; 4687 patients who underwent BS (mean [SD] age, 44.8 [11.6] years; 3822 [81.5%] female) were matched with 4687 individuals (mean [SD] age, 44.7 [13.2] years; 3883 [82.8%] years) who did not undergo BS. The BS group had significantly lower risk of new-onset of HF (HR, 0.60; 95% CI, 0.51-0.70), cardiovascular events (HR, 0.53; 95% CI, 0.44-0.65), cerebrovascular events (HR, 0.59; 95% CI, 0.51-0.69), and coronary artery interventions (HR, 0.47; 95% CI, 0.35-0.63) compared with the non-BS group. Similarly, all-cause mortality was substantially lower in the BS group (HR, 0.56; 95% CI, 0.42-0.74). These outcomes were consistent at follow-up duration of 1, 3, 5, and 7 years.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230236-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>These findings suggest that BS was significantly associated with lower risk of major adverse cardiovascular events and all-cause mortality in patients with NAFLD and obesity.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.7188","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T15:01:58Z","timestamp":1680879718000},"page":"e237188","source":"Crossref","is-referenced-by-count":53,"title":["Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity"],"prefix":"10.1001","volume":"6","author":[{"given":"Arunkumar","family":"Krishnan","sequence":"first","affiliation":[{"name":"Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousaf","family":"Hadi","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinsay A.","family":"Woreta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[{"name":"West Virginia Clinical & Translational Science Institute, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Abunnaja","sequence":"additional","affiliation":[{"name":"WVU Medicine Center for Weight Management, Morgantown, West Virginia"},{"name":"Department of Surgery, West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nova","family":"Szoka","sequence":"additional","affiliation":[{"name":"West Virginia Clinical & Translational Science Institute, Morgantown"},{"name":"Department of Surgery, West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence E.","family":"Tabone","sequence":"additional","affiliation":[{"name":"WVU Medicine Center for Weight Management, Morgantown, West Virginia"},{"name":"Department of Surgery, West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown"},{"name":"WVU Medicine Center for Weight Management, Morgantown, West Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"issue":"4","key":"zoi230236r1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"zoi230236r2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"14","key":"zoi230236r3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi230236r4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease.","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"J Hepatol"},{"issue":"9","key":"zoi230236r5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"3","key":"zoi230236r6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/jcm10030467","article-title":"NAFLD and cardiovascular diseases: epidemiological, mechanistic and therapeutic considerations.","volume":"10","author":"Niederseer","year":"2021","journal-title":"J Clin Med"},{"key":"zoi230236r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease.","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"issue":"3","key":"zoi230236r8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"5","key":"zoi230236r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.0029","article-title":"Association of race with bariatric surgery outcomes.","volume":"154","author":"Wood","year":"2019","journal-title":"JAMA Surg"},{"issue":"1","key":"zoi230236r10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2014.06.006","article-title":"Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.","volume":"236","author":"Kunutsor","year":"2014","journal-title":"Atherosclerosis"},{"issue":"7","key":"zoi230236r11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016947","article-title":"Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the Look AHEAD Study.","volume":"10","author":"Kaze","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"zoi230236r12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size\u2014or why the P value is not enough.","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Grad Med Educ"},{"issue":"13","key":"zoi230236r13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity.","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"issue":"22","key":"zoi230236r14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.","volume":"311","author":"Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"issue":"20","key":"zoi230236r15","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis.","volume":"326","author":"Aminian","year":"2021","journal-title":"JAMA"},{"issue":"21","key":"zoi230236r16","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis.","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi230236r17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2337\/db13-1307","article-title":"Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.","volume":"63","author":"Bojsen-M\u00f8ller","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"zoi230236r18","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis.","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"issue":"10271","key":"zoi230236r19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"zoi230236r20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1001\/jama.2017.20813","article-title":"Lifestyle intervention and medical management with vs without roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study.","volume":"319","author":"Ikramuddin","year":"2018","journal-title":"JAMA"},{"issue":"15","key":"zoi230236r21","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/CIRCULATIONAHA.120.052386","article-title":"Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study.","volume":"143","author":"Doumouras","year":"2021","journal-title":"Circulation"},{"issue":"20","key":"zoi230236r22","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi230236r23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hep.31726","article-title":"Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement.","volume":"74","author":"Hagstr\u00f6m","year":"2021","journal-title":"Hepatology"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2803481\/krishnan_2023_oi_230236_1680183100.98504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T15:02:02Z","timestamp":1680879722000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2803481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.7188","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]}}}